The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Intelligent hydrogels for the oral delivery of chemotherapeutics
Abstract
A novel approach toward improvements of oral chemotherapeutic formulations has evolved, which combines solubilisation (molecular dispersion) of the hydrophobic anticancer drugs in micelles attached to large macromolecules or microparticles. The large size of the macromolecules or microgels prevents the gel components from being transported into the systemic circulation. The discussed gels comprise copolymers of poly(acrylic acid) (PAA) and Pluronic surfactants, linked via C-C bonds. The Pluronic-PAA copolymers are non-irritating when administered orally. The micelles formed in the Pluronic-PAA solutions and in crosslinked microgels can be loaded with chemotherapeutic drugs and then released in contact with the intestine. The microgels are collapsed at the acidic pH of the stomach and expand, thus releasing the loaded drugs at the pH of the lower gastrointestinal tract. Yet the microgels are mucoadhesive and enable longer retention time and prolonged release in the colon. Ease of preparation and formulation of the drugs with the Pluronic-PAA polymers and gels may enable the wider use of oral chemotherapy, resulting in a better patient compliance and improved quality of life of the patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pH responsive behavior of PAA attributes to oral delivery of the drug by the PAA-based drug delivery system [124].”
From Review of Stimuli-Responsive Polymers in Drug Delivery and Textile Application (2019) · cites this paper as [124]
Citations
Cites
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655 · cited 1×
“Although Cremophor EL solubilises and stabilises paclitaxel, it also causes serious side effects, including hypersensitivity reactions, nephrotoxicity, neurotoxicity and cardiotoxicity, and its use is associated with anaphylactoid hypersensitivity reactions, hyperlipidaemia, abnormal lipoprotein patterns, erythrocyte…”
BackgroundPharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452 · cited 8×
“By encapsulating anticancer drugs into nanoparticles, liposomes, or micelles, an improved adhesion to and absorption through the intestinal cells can be achieved, along with the possibility for the drug to escape from recognition by P-gp [1,19,20].”
BackgroundInfluentialTemperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery
Bromberg, L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00121-x · Cited by 838
Self-citationA kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some Analogues
Fassberg, J., & Stella, V. J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810718 · Cited by 464 · cited 1×
“Lactone is converted to carboxylate in a pH-dependent equilibrium (Figure 7) [40].”
BackgroundHandbook of polyelectrolytes and their applications
Tripathy, S. K., Kumar, J., & Nalwa, H. S. (2002) · American Scientific Publishers eBooks · Cited by 423
The Cancer Patient and Quality of Life
Bottomley, A. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2-120 · Cited by 378 · cited 1×
“Advances in oral chemotherapy can thus promote ‘chemotherapy at home’, which would be a new concept of cancer treatment [1-5].”
BackgroundFeng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364 · cited 10×
“By encapsulating anticancer drugs into nanoparticles, liposomes, or micelles, an improved adhesion to and absorption through the intestinal cells can be achieved, along with the possibility for the drug to escape from recognition by P-gp [1,19,20].”
BackgroundInfluentialCamptothecin, over four decades of surprising findings
Lorence, A., & Nessler, C. L. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.09.001 · Cited by 330 · cited 1×
“The camptothecins act as specific inhibitors of topoisomerase I, a critical enzyme involved in DNA replication, transcription and chromosomal structure [6,7].”
BackgroundOral chemotherapy: rationale and future directions.
DeMario, M. D., & Ratain, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2557 · Cited by 293 · cited 1×
“Advances in oral chemotherapy can thus promote ‘chemotherapy at home’, which would be a new concept of cancer treatment [1-5].”
BackgroundBatrakova, E. V., Li, S., Vinogradov, S. V., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29254-5 · Cited by 292 · cited 1×
“Pluronic L61 is known to be a potent doxorubicin efflux suppressor at concentrations up to critical micellar concentration, above which the effects of Pluronics generally plateau and then decay [45-47].”
BackgroundBlock copolymer-based formulation of doxorubicin. From cell screen to clinical trials
Alakhov, V., Klinski, E., Li, S., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., & Kabanov, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00064-8 · Cited by 266 · cited 1×
“Pluronic L61 is known to be a potent doxorubicin efflux suppressor at concentrations up to critical micellar concentration, above which the effects of Pluronics generally plateau and then decay [45-47].”
Backgroundvon Pawel, J., Gatzemeier, U., Pujol, J.-L., Moreau, L., Bildat, S., Ranson, M., Richardson, G., Steppert, C., Rivière, A., Camlett, I., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1743 · Cited by 234 · cited 1×
“Oral topotecan demonstrated better response rates and longer median survival of patients with relapsed small cell lung cancer, compared with patients treated intravenously [9,10].”
Batrakova, E. V., Li, S., Miller, D. W., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018990706838 · Cited by 206 · cited 1×
“Pluronic L61 is known to be a potent doxorubicin efflux suppressor at concentrations up to critical micellar concentration, above which the effects of Pluronics generally plateau and then decay [45-47].”
BackgroundHydrogels for oral delivery of therapeutic proteins
Peppas, N. A., Wood, K. M., & Blanchette, J. O. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.6.881 · Cited by 161 · cited 1×
“Thus, the major premise of the dosage forms based on intelligent hydrogels is to protect the drug from the acidic and proteolytic environment and/or prevent its undesirable systemic delivery from the upper GI tract, and facilitate its targeted absorption in the lower parts of the GI tract [23-26].”
BackgroundDually Responsive Microgels from Polyether-Modified Poly(acrylic acid): Swelling and Drug Loading
Bromberg, L. E., Temchenko, M., & Hatton, T. A. (2002) · Langmuir · doi:10.1021/la011868l · Cited by 145 · cited 5×
“The micellar ‘intra-gel’ aggregates solubilise hydrophobic drugs such as paclitaxel (Figure 4), whereas the presence of carboxyls allows for the loading of positively charged drugs [31,32].”
BackgroundSelf-citationBioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor
Schellens, J. H. M., Creemers, G. J. M., Beijnen, J. H., Rosing, H., de Boer-Dennert, M. M., McDonald, M., Davies, B., & Verweij, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.243 · Cited by 131 · cited 1×
“Oral topotecan demonstrated better response rates and longer median survival of patients with relapsed small cell lung cancer, compared with patients treated intravenously [9,10].”
Design and Development of Multiparticulate System for Targeted Drug Delivery to Colon
Chourasia, M. K., & Jain, S. (2004) · Drug Delivery · doi:10.1080/10717540490445955 · Cited by 120 · cited 1×
“Thus, the major premise of the dosage forms based on intelligent hydrogels is to protect the drug from the acidic and proteolytic environment and/or prevent its undesirable systemic delivery from the upper GI tract, and facilitate its targeted absorption in the lower parts of the GI tract [23-26].”
BackgroundBioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels
Bromberg, L. E., Temchenko, M., Alakhov, V. Y., & Hatton, T. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.030 · Cited by 120 · cited 3×
“Examination by means of transient rheological properties, tensile tests and atomic force microscopy revealed significant bioadhesion of the Pluronic-PAA gelled solutions and crosslinked microgels to rat intestinal tissue [30] and mucous substrates over a range of pH values [48].”
BackgroundSelf-citationBarreiro-Iglesias, R., Bromberg, L. E., Temchenko, M., Hatton, T. A., Concheiro, Á., & Alvarez‐Lorenzo, C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.007 · Cited by 118 · cited 3×
“Recently, it has been demonstrated that the solubilisation into the Pluronic-PAA polymer micelles provided an effective barrier against drug decomposition [35].”
BackgroundSelf-citationBromberg, L. E., Temchenko, M., & Hatton, T. A. (2003) · Langmuir · doi:10.1021/la030187i · Cited by 118
Self-citationBromberg, L. E., & Alakhov, V. Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00419-4 · Cited by 112 · cited 2×
“Cytotoxicity studies confirmed that the transportenhancing properties of the microgels were not due to the damage of the Caco-2 cell monolayers [44].”
BackgroundSelf-citationPrinciples of transmucosal delivery of therapeutic agents
Blanchette, J. O., Kavimandan, N. J., & Peppas, N. A. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.006 · Cited by 97
Bromberg, L. E., & Barr, D. P. (1999) · Macromolecules · doi:10.1021/ma981946k · Cited by 96 · cited 1×
“The enhancement of the solubility of compounds by micelles is due to the hydrophobic core of the micelle providing a suitable microenvironment for the hydrophobic solute [29,36].”
BackgroundSelf-citationThe Potential of Liposomes in Oral Drug Delivery
Rogers, J. A., & Anderson, K. E. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i5.10 · Cited by 94 · cited 8×
“By encapsulating anticancer drugs into nanoparticles, liposomes, or micelles, an improved adhesion to and absorption through the intestinal cells can be achieved, along with the possibility for the drug to escape from recognition by P-gp [1,19,20].”
BackgroundInfluentialSchilsky, R. L., Levin, J., West, W. H., Wong, A., Colwell, B., Thirlwell, M. P., Ansari, R., Bell, W. N., White, R. L., Yates, B. B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1519 · Cited by 83 · cited 1×
“For example, oral delivery of 5-fluorouracil (5-FU), a chemotherapeutic agent widely used in the treatment of solid malignancies [13], has not shown improvements in overall survival rate in patients with colorectal cancer [14].”
BackgroundAdhesion of Polyether-Modified Poly(acrylic acid) to Mucin
Cleary, J., Bromberg, L. E., & Magner, E. (2004) · Langmuir · doi:10.1021/la048993s · Cited by 76 · cited 1×
“Examination by means of transient rheological properties, tensile tests and atomic force microscopy revealed significant bioadhesion of the Pluronic-PAA gelled solutions and crosslinked microgels to rat intestinal tissue [30] and mucous substrates over a range of pH values [48].”
BackgroundSelf-citationThe co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients
Malingré, M. M., Schellens, J. H. M., van Tellingen, O., Ouwehand, M., Bardelmeijer, H. A., Rosing, H., Jansen, S. E., Koopman, F. J., Schot, M. E., Huinink, W. W. T. B., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2118 · Cited by 72 · cited 1×
“When administered orally as a cosolvent with paclitaxel, Cremophor EL limits the absorption of the paclitaxel in cancer patients [12].”
BackgroundBromberg, L. E., Temchenko, M., Alakhov, V. Y., & Hatton, T. A. (2005) · Langmuir · doi:10.1021/la047893j · Cited by 63 · cited 2×
“The microgels can contain either permanent or degradable crosslinks containing disulfide (S–S) or azo (-N=N-) bonds [34].”
BackgroundSelf-citationAlakhov, V. Y., Pietrzyński, G., Patel, K., Kabanov, A. V., Bromberg, L. E., & Hatton, T. A. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044427 · Cited by 57 · cited 5×
“(2005) 2(6) study [49], tablet dosage forms were tested in vitro, whereas the MA release from the equilibrium-swollen microgels as well as the radioactively labelled microgel passage through the GI tract were evaluated in rats.”
BackgroundMethodSelf-citationThiomers for oral delivery of hydrophilic macromolecular drugs
Bernkop‐Schnürch, A., Hoffer, M. H., & Kafedjiiski, K. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.87 · Cited by 57 · cited 1×
“In this regard, the Pluronic-PAA copolymers are comparable to the thiolated polymers (thiomers), emerging as a promising new tool in oral delivery [50].”
BackgroundBromberg, L. E., & Temchenko, M. (1999) · Langmuir · doi:10.1021/la9904760 · Cited by 47
Self-citationKanard, A., Jatoi, A., Castillo, R., Geyer, S. M., Schulz, T. K., Fitch, T. R., Rowland, K. M., Nair, S., Krook, J. E., & Kugler, J. W. (2003) · Lung Cancer · doi:10.1016/j.lungcan.2003.09.012 · Cited by 44 · cited 1×
“Analogously, vinorelbine (a semisynthetic derivative of Vinca alkaloid), approved in the intravenous form for the treatment of metastatic non-small cell lung cancer in elderly patients, shows only minimal activity when administered orally [17].”
BackgroundGridelli, C., Manegold, C., Mali, P., Reck, M., Portalone, L., Castelnau, O., Stahel, R. A., Betticher, D. C., Pless, M., Pons, J. T., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.028 · Cited by 44 · cited 1×
“Specific formulations using vinorelbine can improve its activity and tolerability [18].”
BackgroundOral Chemotherapeutic Delivery: Design and Cellular Response
Blanchette, J. O., & Peppas, N. A. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8973-8 · Cited by 43 · cited 1×
“Notable recent reports in the area of formulations specifically designed for oral chemotherapeutics include work by Peppas and colleagues [5,21,22], which describe hydrogel nanospheres composed of methacrylic acid and poly(ethylene glycol) (PEG), and loaded with a chemotherapeutic agent bleomycin.”
BackgroundThermodynamics of Temperature-Sensitive Polyether-Modified Poly(acrylic acid) Microgels
Bromberg, L. E., Temchenko, M., Moeser, G. D., & Hatton, T. A. (2004) · Langmuir · doi:10.1021/la0359530 · Cited by 41 · cited 1×
“When chemically crosslinked, the Pluronic-PAA copolymers result in networks that on swelling result in microgels, that is, spherical particles ranging in diameter from tens to hundreds of microns, with the size depending on the polyether involved in the synthesis [31-34].”
BackgroundSelf-citationHuibers, P. D. T., Bromberg, L. E., Robinson, B. H., & Hatton, T. A. (1999) · Macromolecules · doi:10.1021/ma990181t · Cited by 40 · cited 1×
“Structure of Pluronic-PAA micelle, comprising of hydrophobic core (diameter ~ 6 nm) of PPO chains surrounded by protective corona (diameter ~ 20 nm) composed of PEO and PAA segments [29,38].”
BackgroundSelf-citationIntelligent Polyelectrolytes and Gels in Oral Drug Delivery
Bromberg, L. E. (2003) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201033489702 · Cited by 33 · cited 6×
“Thus, the major premise of the dosage forms based on intelligent hydrogels is to protect the drug from the acidic and proteolytic environment and/or prevent its undesirable systemic delivery from the upper GI tract, and facilitate its targeted absorption in the lower parts of the GI tract [23-26].”
BackgroundMethodSelf-citationNukatsuka, M., Fujioka, A., Nakagawa, F., Oshimo, H., Kitazato, K., Uchida, J., Sugimoto, Y., Nagayama, S., & Fukushima, M. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1531 · Cited by 31 · cited 1×
“The oral bioavailability of 5-FU, the catabolism of which is mediated by dihydropyrimidine dehydrogenase (DPD), an enzyme that is especially active in metastatic tumours, is generally low but can be improved by 5-FU prodrugs and analogues such as DPD-inhibiting fluoropyrimidines, eniluracil, as well as coadministratio…”
BackgroundInteractions among proteins and hydrophobically modified polyelectrolytes
Bromberg, L. E. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775659 · Cited by 24 · cited 2×
“Due to the numerous carboxylic groups in the corona, negatively charged at intestinal pH, the presence of the Pluronic-PAA copolymers in the protein solutions does not induce any significant changes in the tertiary structure of the negatively charged insulin, haemoglobin and albumin, but very pronounced changes are ob…”
BackgroundSelf-citationRecent Developments in Oral Chemotherapy Options for Gastric Carcinoma
Ajani, J. A., & Takiuchi, H. (1999) · Drugs · doi:10.2165/00003495-199958003-00012 · Cited by 23
Cellular evaluation of oral chemotherapy carriers
Blanchette, J. O., & Peppas, N. A. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30243 · Cited by 22 · cited 2×
“The swollen nanospheres were shown to release bleomycin in response to a pH increase similar to that seen when passing from the stomach into the upper small intestine [21].”
BackgroundTopoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck
Murphy, B. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.1.85 · Cited by 21 · cited 1×
“The camptothecins act as specific inhibitors of topoisomerase I, a critical enzyme involved in DNA replication, transcription and chromosomal structure [6,7].”
BackgroundPharmacology of Fluorinated Pyrimidines: Eniluracil
Baker, S. D. (2000) · Investigational New Drugs · doi:10.1023/a:1006453500629 · Cited by 20 · cited 1×
“The oral bioavailability of 5-FU, the catabolism of which is mediated by dihydropyrimidine dehydrogenase (DPD), an enzyme that is especially active in metastatic tumours, is generally low but can be improved by 5-FU prodrugs and analogues such as DPD-inhibiting fluoropyrimidines, eniluracil, as well as coadministratio…”
BackgroundFinal Report on the Safety Assessment of Carbomers-934, -910, -934P, -940, -941, and -962
(1990) · Journal of the American College of Toxicology · doi:10.3109/10915818209013151 · Cited by 17
Phase I study of oral topotecan in hematological malignancies.
Beran, M., O'Brien, S. M., Thomas, D. A., Tran, H. T., Cortes, J. E., Giles, F. J., Estey, E. H., & Kantarjian, H. M. (2003) · PubMed · Cited by 12
Díaz, R., Segura, Á., Aparicio, J., Calderero, V., Guerrero, Á., & Pellín, L. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.6.599 · Cited by 7 · cited 1×
“For example, oral delivery of 5-fluorouracil (5-FU), a chemotherapeutic agent widely used in the treatment of solid malignancies [13], has not shown improvements in overall survival rate in patients with colorectal cancer [14].”
Background
Research works printed but not linked: 4
- BERAN M, 2003, Clin. Cancer Res., 9, 4084
- NUKATSUKA M, 2004, Int. J. Oncol., 25, 1531
- HAEBERLIN B, 1992, USA, 1
- BROMBERG L, 2001, USA, 369
Cited by
Herzberger, J., Niederer, K., Pohlit, H., Seiwert, J., Worm, M., Wurm, F. R., & Frey, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00441 · Cited by 865
Polymerization Reactions and Modifications of Polymers by Ionizing Radiation
Ashfaq, A., Clochard, M.-C., Coqueret, X., Dispenza, C., Driscoll, M. S., Ulański, P., & Al-Sheikhly, M. (2020) · Polymers · doi:10.3390/polym12122877 · Cited by 459
Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications
Larrañeta, E., Stewart, S., Ervine, M., Al-Kasasbeh, R., & Donnelly, R. (2018) · Journal of Functional Biomaterials · doi:10.3390/jfb9010013 · Cited by 303
“Oral drug delivery is the preferred route of drug administration due to its simplicity.”
BackgroundMethodPolymeric micelles in oral chemotherapy
Bromberg, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.018 · Cited by 264
Self-citationSoni, G., & Yadav, K. S. (2016) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.04.001 · Cited by 207
“…has been considerable work on hydrogels, which are described as hydrophilic three dimensional polymer networks that are able to take up large amounts of water or physiological fluid, while maintaining their internal network structure (Peppas et al., 2000; Bromberg, 2005; Raemdonck et al., 2009a).”
Background
Metadata
- Authors
- Bromberg, L.
- Affiliations
- Massachusetts Institute of Technology (US)
- Corresponding author
- Bromberg, Lev
- ORCID
- Bromberg, Lev
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2005-11
- Volume
- 2
- Issue
- 6
- Pages
- 1003-1013
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2144014845
- Cited by
- 42
- References
- 47
- Citations by year
- 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 3 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 5 · 2012: 1
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Delivery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- oral chemotherapy, hydrogels, poly(acrylic acid), Pluronic surfactants, micelles, microgels, colon-targeted drug delivery, pH-responsive drug release, mucoadhesion, hydrophobic anticancer drugs, medication adherence
- MeSH terms
- Acrylic Resins, Administration, Oral, Animals, Antineoplastic Agents, Biological Availability, Chemistry, Pharmaceutical, Delayed-Action Preparations, Doxorubicin, Drug Carriers, Drug Stability, Humans, Hydrogen-Ion Concentration, Intestinal Absorption, Micelles, Particle Size, Solubility, Surface-Active Agents, Hydrogels, Poloxamer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.